Cargando…
Stem Cell-Like Gene Expression in Ovarian Cancer Predicts Type II Subtype and Prognosis
Although ovarian cancer is often initially chemotherapy-sensitive, the vast majority of tumors eventually relapse and patients die of increasingly aggressive disease. Cancer stem cells are believed to have properties that allow them to survive therapy and may drive recurrent tumor growth. Cancer ste...
Autores principales: | Schwede, Matthew, Spentzos, Dimitrios, Bentink, Stefan, Hofmann, Oliver, Haibe-Kains, Benjamin, Harrington, David, Quackenbush, John, Culhane, Aedín C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3594231/ https://www.ncbi.nlm.nih.gov/pubmed/23536770 http://dx.doi.org/10.1371/journal.pone.0057799 |
Ejemplares similares
-
A network model for angiogenesis in ovarian cancer
por: Glass, Kimberly, et al.
Publicado: (2015) -
Angiogenic mRNA and microRNA Gene Expression Signature Predicts a Novel Subtype of Serous Ovarian Cancer
por: Bentink, Stefan, et al.
Publicado: (2012) -
iBBiG: iterative binary bi-clustering of gene sets
por: Gusenleitner, Daniel, et al.
Publicado: (2012) -
MicroRNA paraffin-based studies in osteosarcoma reveal reproducible independent prognostic profiles at 14q32
por: Kelly, Andrew D, et al.
Publicado: (2013) -
Integrated Analysis of Multiple Microarray Datasets Identifies a Reproducible Survival Predictor in Ovarian Cancer
por: Konstantinopoulos, Panagiotis A., et al.
Publicado: (2011)